Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > TLT.. NOT A ONE TRICK PONY

<< Previous

Bullboard Posts

Next >>

Comment by Kayz88on Apr 05, 2024 5:21pm

185 Views

Post# 35973945

RE:RE:RE:TLT.. NOT A ONE TRICK PONY

I tend to agree, the idea sounds great in theory but introduces so many more variables into the equation:

1) It's a moonshot, we can barely afford to finish a phase 2 trial of bladder cancer
2) Our management team has issued something similar in the past with COVID vaccines, to no avail. Money was spent, no updates.
3) TLT is running with a handful of employees so I worry if BTD would take a backseat and not get any attention.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec